MDVLQ — Medavail Holdings Share Price
0.000.00%
Last trade - 00:00- $0.00m
- -$12.65m
- $43.11m
- 41
- 84
- 12
- 42
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0 | ||
| Price to Tang. Book | 0 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -123.1% | ||
| Return on Equity | -146.62% | ||
| Operating Margin | -132.99% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 0.36 | 1.03 | 13.97 | 22.13 | 43.11 | 3 | 6.9 | 141.39% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
MedAvail Holdings, Inc. is a pharmacy technology and services company. The Company is focused on developing and commercializing a self-service pharmacy, mobile application, and kiosk. Its core technology and product, the MedAvail MedCenter (the MedCenter), is a pharmacist-controlled, patient-interactive, prescription dispensing system akin to a pharmacy in a box. It operates through two segments: Retail Pharmacy Services and Pharmacy Technology. The Retail Pharmacy Services segment operates as SpotRx, or the Pharmacy, which is a full-service retail pharmacy utilizing its automated pharmacy technology, primarily servicing Medicare patients in the United States. The Pharmacy Technology segment, through its MedAvail Technologies, Inc., develops and commercializes the MedCenter for direct sale or subscription to third-party customers, including some of the healthcare providers and systems, as well as large retail chains that provide full retail-pharmacy services using its technology.
Directors
- Robert Faulkner CHM (58)
- Mark Doerr CEO
- Brian Schlerf CFO (44)
- Ramona Seabaugh CFO
- Joan O'Rourke CEX
- Will Misloski CMO (50)
- Neil Prezioso OTH (62)
- Dave Rawlins OTH (40)
- Paul Johnson DRC
- Laurie McGraw DRC
- Gerald Gradwell IND (53)
- Michael Kramer IND (44)
- Glen Stettin IND (57)
- Last Annual
- December 31st, 2022
- Last Interim
- June 30th, 2023
- Incorporated
- November 18th, 2020
- Public Since
- October 20th, 2008
- No. of Shareholders
- 4,375
- No. of Employees
- 279
- Sector
- Machinery, Equipment & Components
- Industry
- Industrials
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 1,613,911
- Address
- 4720 E Cotton Gin Loop, Suite 220, PHOENIX, 85040
- Web
- https://investors.medavail.com/overview/default.aspx
- Phone
- +1 9058120023
- Contact
- Caroline Paul
- Auditors
- PricewaterhouseCoopers LLP
Upcoming Events for MDVLQ
Q3 2023 MedAvail Holdings Inc Earnings Release
Q4 2023 MedAvail Holdings Inc Earnings Release
Similar to MDVLQ
3DX Industries
Pink Sheets on Nasdaq
420 Property Management
Pink Sheets on Nasdaq
Abb
Pink Sheets on Nasdaq
Abound Energy
Pink Sheets on Nasdaq
AI Technology.
Pink Sheets on Nasdaq
FAQ
What is the Medavail Holdings share price?
As of Today at 22:00 UTC, shares in Medavail Holdings are trading at $0.00. This share price information is delayed by 15 minutes.
How has the Medavail Holdings share price performed this year?
Shares in Medavail Holdings last closed at $0.00 and the price had moved by -100% over the past 365 days. In terms of relative price strength the Medavail Holdings share price has underperformed the S&P500 Index by -100% over the past year.
What are the analyst and broker recommendations for Medavail Holdings?
The overall consensus recommendation for Medavail Holdings is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Medavail Holdings dividend yield?
Medavail Holdings does not currently pay a dividend.
Does Medavail Holdings pay a dividend?
Medavail Holdings does not currently pay a dividend.
When does Medavail Holdings next pay dividends?
Medavail Holdings does not currently pay a dividend.
How do I buy Medavail Holdings shares?
To buy shares in Medavail Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Medavail Holdings?
As of the previous close price of $0.00, shares in Medavail Holdings had a market capitalisation of $0.00m.
Where are Medavail Holdings shares listed?
Here are the trading details for Medavail Holdings:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: MDVLQ
What kind of share is Medavail Holdings?
Based on an overall assessment of its quality, value and momentum Medavail Holdings is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Medavail Holdings share price forecast for 2024?
The analyst consensus target price for shares in Medavail Holdings is $4.00. That is 3999900% above the last closing price of $0.00.
Analysts covering Medavail Holdings currently have a consensus Earnings Per Share (EPS) forecast of -$0.30 for the next financial year.
What is the trend in the Medavail Holdings share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Medavail Holdings. Over the past six months, its share price has underperformed the S&P500 Index by -100%.
As of the last closing price of $0.00, shares in Medavail Holdings were trading -100% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Medavail Holdings PE Ratio?
The Medavail Holdings PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Medavail Holdings?
Medavail Holdings' management team is headed by:
- Robert Faulkner - CHM
- Mark Doerr - CEO
- Brian Schlerf - CFO
- Ramona Seabaugh - CFO
- Joan O'Rourke - CEX
- Will Misloski - CMO
- Neil Prezioso - OTH
- Dave Rawlins - OTH
- Paul Johnson - DRC
- Laurie McGraw - DRC
- Gerald Gradwell - IND
- Michael Kramer - IND
- Glen Stettin - IND